The Identification and Characterization of a Noncontinuous
Calmodulin-binding Site in Noninactivating
Voltage-dependent KCNQ Potassium Channels*
Eva
Yus-Nájera,
Irene
Santana-Castro, and
Alvaro
Villarroel
From the Instituto Cajal, Consejo Superior de
Investigaciones, Avenida, Dr. Arce 37, 28002 Madrid, Spain
Received for publication, April 29, 2002, and in revised form, May 22, 2002
 |
ABSTRACT |
We show here that in a yeast two-hybrid assay
calmodulin (CaM) interacts with the intracellular C-terminal region of
several members of the KCNQ family of potassium channels. CaM
co-immunoprecipitates with KCNQ2, KCNQ3, or KCNQ5 subunits better in
the absence than in the presence of Ca2+. Moreover,
in two-hybrid assays where it is possible to detect interactions with
apo-CaM but not with Ca2+-bound calmodulin, we localized
the CaM-binding site to a region that is predicted to contain two
-helices (A and B). These two helices encompass ~85 amino acids,
and in KCNQ2 they are separated by a dispensable stretch of ~130
amino acids. Within this CaM-binding domain, we found an IQ-like
CaM-binding motif in helix A and two overlapping consensus
1-5-10 CaM-binding motifs in helix B. Point mutations in helix
A or B were capable of abolishing CaM binding in the two-hybrid assay.
Moreover, glutathione S-transferase fusion proteins
containing helices A and B were capable of binding to CaM, indicating
that the interaction with KCNQ channels is direct. Full-length CaM
(both N and C lobes) and a functional EF-1 hand were required for these
interactions to occur. These observations suggest that apo-CaM is bound
to neuronal KCNQ channels at low resting Ca2+ levels and
that this interaction is disturbed when the [Ca2+] is
raised. Thus, we propose that CaM acts as a mediator in the Ca2+-dependent modulation of KCNQ channels.
 |
INTRODUCTION |
The KCNQ transmembrane proteins are members of a family of
voltage-dependent potassium selective channels that are
involved in the control of cellular excitability. Remarkably, mutations in four of the five known members of this family have been associated with different hereditary human disorders. While mutations in the KCNQ1
subunit (KvQT1) lead to arrhythmia in the human long QT
syndrome, mutations in KCNQ2 or KCNQ3 are associated with a benign form
of epilepsy. It has also been shown that KCNQ4 is mutated in a
dominant form of progressive hearing loss (1).
With regards to the normal physiology of this protein family, the KCNQ2
and KCNQ3 subunits have been shown to form M-type potassium channels
whose expression is restricted to neuronal tissue (2). Moreover, in
some brain areas and neuronal tissues, KCNQ4 and KCNQ5 also contribute
to the formation of M channels, suggesting that the different
combinations of KCNQ subunits may be in part responsible for the
diversity of M channel properties (1). The M current
(IM) is a subthreshold noninactivating
voltage-dependent potassium current that is found in many
neuronal cell types. The M current controls membrane excitability, and
it has been shown to be modulated by a variety of intracellular signals
that in turn dramatically affect the firing rate of neurons. Among
those intracellular signals, Ca2+ has been shown to mediate
the inhibition of IM by B2
bradykinin receptors in sympathetic neurons (3). Indeed, intracellular Ca2+ can suppress the activity of M channels under
conditions that do not support enzymatic activities such as
phosphorylation (4). This phenomenon suggests that an intermediary
might be involved in this Ca2+-dependent modulation.
In a search for candidates that might mediate the effects of
Ca2+ in modulating IM, we screened a
human brain cDNA library using the yeast two-hybrid system. We
found that calmodulin (CaM)1
bound to the C-terminal region of KCNQ channels. CaM is a small Ca2+-binding protein that acts as a ubiquitous
intracellular Ca2+ sensor in the regulation of a growing
diverse array of ion channels (5). Efforts to define common
characteristics of CaM binding have indicated that it associates with
short
-helical sequences within its targets (6-8). However, it
appears that the interaction of CaM with KCNQ channels does not conform
to this simple model. Rather, our data suggest that the CaM-binding
site in KCNQ channels is formed by two
-helices that are separated
by a stretch of ~130 amino acids. We hypothesize that those two
helices come into close proximity in the tertiary structure,
facilitating CaM binding.
 |
EXPERIMENTAL PROCEDURES |
Yeast Two-hybrid Analysis--
A cDNA generated by PCR
encoding amino acids 310-844 of the human KCNQ2 subunit (9) was
subcloned in frame with the GAL4 DNA-binding domain of the yeast vector
pGBKT7 (CLONTECH) to be used as bait in a yeast
two-hybrid screen. The reporter yeast strain Y190 was sequentially
transformed with this plasmid and with a human brain cDNA library
subcloned in pACT2 (CLONTECH, catalog number HL
4004 AH, lot 5008, mRNA source: normal, whole brain from a
37-year-old Caucasian male, whose probable cause of death was trauma).
We screened >2.5 × 106 co-transformants that were
selected on medium lacking histidine (in the presence of 25 mM 3-aminotriazole), leucine, and tryptophan and
assayed for
-galactosidase activity.
Constructs containing point mutations and deletions were generated by
PCR as described previously (10), sequenced, and subcloned into pGBKT7
(CLONTECH bait vector). The mutated constructs were co-transformed, along with a rat CaM cDNA in pGADT7
(CLONTECH prey vector), into Y190 to asses their
interaction in vivo. Yeast extracts were analyzed to confirm
the presence of Myc-tagged bait proteins by Western blotting with the
9E10 monoclonal anti-c-Myc antibody. For liquid quantitative
-galactosidase assays,
O-nitrophenyl-
-D-galactopyranoside was used
as the substrate, and the number of
-galactosidase units was
calculated according to the CLONTECH protocol.
We also monitored the activity of the His reporter when using the low
copy two-hybrid system, pPC97 and pPC86 (Invitrogen), with the yeast
Y190 strain. Colonies growing in medium lacking leucine and tryptophan
were grown in 1 ml of liquid medium overnight. The following morning
the culture was diluted 100-fold in 10 mM Tris, 1 mM EDTA buffer and spotted on a Leu
Trp
His
plate with 10-50 mM
3-aminotriazole. After 2-4 days at 30 °C, the strength of the
interaction was assessed by the size and color of the colonies.
In Vitro Binding and Western Blot--
Recombinant rat CaM was
produced in BL21 Escherichia coli and purified as described
(11). Different regions of human KCNQ subunits were generated by PCR,
subcloned into the glutathione S-transferase (GST) fusion
vector pGEX (Pharmacia Corp.) and transformed into BL21 E. coli. The synthesis of fusion proteins was induced with 0.5 mM isopropyl-
-D-thiogalactopyranoside for
4 h at 30 °C. The cells were resuspended in chilled GST buffer
that included protease inhibitors (20 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, 0.5% Triton X-100, pH 8, plus 1 mM phenylmethylsulfonyl fluoride, 1 µg/ml each
aprotinin and leupeptine) and lysed by sonication at 4 °C, and the
protein was recovered by immobilization on glutathione-Sepharose 4B
beads (Amersham Biosciences). After extensive washing, the immobilized
proteins were equilibrated in pull-down buffer (25 mM
Hepes, 120 mM KCl, 5 mM NaCl, pH 7.5) with
either 2 mM CaCl2 or 5 mM EGTA. Rat
calmodulin (10 µg) was added to the beads and incubated for 45 min at
room temperature. After three washes, the proteins were recovered,
separated by 15% SDS-PAGE in the presence of 5 mM EGTA,
and transferred to Probond nitrocellulose (Schleicher & Schuell) for
Western blotting. The nitrocellulose was blocked with 5% nonfat dry
milk in 0.05% Tween 20 in phosphate-buffered saline, incubated with
the primary antibody (monoclonal anti-CaM from Upstate, diluted 1:2000
in blocking buffer) overnight at 4 °C, washed, and incubated with
horseradish peroxidase-conjugated goat anti-mouse IgG secondary
antibody (Bio-Rad) diluted 1:5000 in blocking buffer. Antibody binding
was detected using enhanced chemiluminiscence and ECL hyperfilm
(Amersham Biosciences).
Antibody Production--
Divergent sequences from the
intracellular N- and C-terminal regions of the different KCNQ channels
were used to generate GST fusion proteins that were then used to
produce antisera in rabbits. The specificity of the antisera produced
was tested in immunoblots of membrane lysates of cells stably or
transiently expressing different KCNQ subunits. A full description of
the characterization of these antisera will be published
elsewhere.2
Immunoprecipitation--
Stable (kindly provided by B. S. Jensen, NeuroSearch) or transient HEK293 cells expressing human KCNQ
subunits were maintained in Dulbecco's modified Eagle's medium
supplemented with 10% fetal calf serum at 37 °C in 5%
CO2. Transient expression was achieved with the KCNQ
expression plasmid using LipofectAMINE 2000 (Invitrogen). For
immunoprecipitation experiments, confluent 60-mm dishes were washed
twice with ice-cold phosphate-buffered saline and solubilized for
1 h in 400 µl of immunoprecipitation buffer (50 mM
Tris-HCl, 150 mM NaCl, 2 mM EDTA, 1% Triton
X-100, pH 7.5) including protease inhibitors as above, and phosphatase
inhibitors (1 mM NaF, 1 mM
-glycerophosphate, and 5 mM pirophosphate). The cell
lysates were centrifuged at 12,000 × g for 20 min to
remove insoluble material, and the protein concentration was determined
with the Bio-Rad protein assay. The lysate was diluted 10-fold in
immunoprecipitation buffer, and bovine serum albumin was added to a
final concentration of 1 mg/ml. Rabbit anti-KCNQ subunit-specific
antibodies were added at 4 mg/ml and incubated for 3 h at 4 °C
with agitation. Immunocomplexes were recovered with 40 µl of
equilibrated protein A-agarose (Santa Cruz) and washed with
immunoprecipitation buffer. The proteins were eluted in Laemmli's
buffer and resolved in 8% SDS-PAGE for the channels or 15% SDS-PAGE
for CaM. The rabbit antisera to KCNQ channels were used at 1:500
dilution, and the peroxidase-conjugated protein A/G (Pierce) was used
at 1:5000 dilution.
Fluorimetric Determination of CaM Binding--
CaM (100 µl at
10 mg/ml) was diluted 10-fold in 100 mM Tris-HCl, 20 mM CaCl2, pH 8.5. Dansyl chloride dissolved in
acetone (2.17 mg/ml) was added (12.5 µl) to achieve a final
concentration of 100 µM. The mixture was incubated at
room temperature in the dark for 2 h, vortexing every 20 min.
Unincorporated dansyl was eliminated using a 1-ml G-25 Sepharose
column. The concentration of dansyl-calmodulin used in all experiments
was 200 nM, unless noted otherwise.
Fluorescence spectra were recorded in a Perkin-Elmer fluorescence
spectrophotometer in a final volume of 3 ml (light path, 1 cm).
Dansyl-CaM was diluted in binding buffer (25 mM Tris-HCl, 120 mM KCl, 5 mM NaCl, with either 5 mM EGTA or 2 mM Ca2+, pH 7.4). The
excitation wavelength was 340 nm, and the emissions were collected from
450 to 600 nm (0.5-nm steps).
 |
RESULTS |
CaM Interacts with the Intracellular C-terminal Region of KCNQ
Channels--
Potassium channels that are members of the KCNQ protein
family have been implicated in pathological conditions affecting the nervous system and in the physiological regulation of excitable cells.
Indeed, the activity of channels containing KCNQ subunits can affect
aspects of the behavior of the cell as important as their firing rate.
To identify proteins capable of modulating the activity of these
channels, we have performed a yeast two-hybrid screen of a human brain
cDNA library using the intracellular C-terminal region of
human-KCNQ2 as bait (534 amino acids).
We identified 32 positive clones that grew in the absence of histidine
(25 mM 3-aminotriazole added), leucine, and tryptophan and
that presented
-galactosidase activity. Of these, 19 clones were
identified as the product of the gene CALM2, and 13 clones were
identified as the product of the gene CALM3. Both genes encode variants
of CaM and have an identical amino acid sequence. This interaction was
confirmed in a second assay where CaM was used as bait and the
C-terminal region of KCNQ2 or KCNQ3 was used as prey, demonstrating
that the association of CaM with KCNQ subunits was independent of which
protein is fused to the binding or activation domain.
Other regions of the KCNQ2 intracellular domain were also studied to
determine whether they too were capable of interacting with CaM. We
tested the N-terminal region
(Met1-Arg89), the loop connecting the
second and third transmembrane domains (Arg144-Ile173), and the loop connecting the
fourth and fifth transmembrane domain
(Leu206-Ala235). We also tested the pore
region (Glu254-Leu292) that connects the fifth
and sixth transmembrane domains because an interaction of the
equivalent region of KCNQ1 with the C-terminal region of minK has been
demonstrated in the two-hybrid assay (12). We were unable to observe
any interaction between the constructs encoding these regions and CaM
in the two-hybrid assay, despite the detection of these Myc-tagged
hybrid proteins in immunoblots of lysates from transformed yeast (not shown).
The C-terminal domain of KCNQ channels commences with a region that is
highly conserved between several members of this family and that is
followed by a more divergent region. To study the domain to which CaM
binds in more detail, we divided the C-terminal region of KCNQ2 and
KCNQ3 into two overlapping parts and found that CaM interacted only
with the initial, more highly conserved region (see Fig. 2). The
overall similarity of this initial C-terminal region as defined by the
Clustal method of DNA-Star software ranges from 38 to 45% for KCNQ2-5
subunits, and the similarity between KCNQ1 and the other KCNQ channels
ranges from 22 to 25%. Using this C-terminal region as bait (or the
whole C-terminal region; not shown), we found that each member of the
KCNQ channel family was capable of interacting with CaM. Furthermore,
when the interaction was quantified with a liquid
-galactosidase
assay, the binding of CaM appeared to be stronger for the KCNQ1 and
KCNQ3 C-terminal regions than for those of KCNQ2, KCNQ4, or KCNQ5. The
values relative to the quantification obtained with KCNQ1 (aa 250-456,
n
5) were 48.7 ± 3.3% for KCNQ2 (aa
310-550), 150.0 ± 14.8% for KCNQ3 (aa 349-556), 22.1 ± 2.7% for KCNQ4 (aa 316-571), and 77.7 ± 24.6% for KCNQ5 (aa
309-524). The significance of these differences remains unclear.
CaM Interacts with Full-length KCNQ Channels--
To determine
whether CaM associates directly with full-length channels inserted into
the membrane, we immunoprecipitated KCNQ2 from solubilized membranes of
transiently transfected HEK293T cells. A ~20-kDa band was recognized
by a CaM-specific antibody in the immunoprecipitate obtained in
Ca2+-free conditions with antisera to the KCNQ2 subunits
but not with preimmune serum (Fig. 1). In
the presence of calcium, CaM was also co-immunoprecipitated, although
the amount that could be detected was reduced.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 1.
CaM and KCNQ2, KCNQ3, or KCNQ5
co-immunoprecipitate from transfected cells. Membrane preparations
from HEK293T cells transiently expressing KCNQ2 or stably expressing
KCNQ3 or KCNQ5 subunits were solubilized and immunoprecipitated in the
absence ( ) or presence (+) of Ca2+ (with the addition of
5 mM EGTA or 2 mM Ca2+,
respectively). The immunoprecipitations were performed with antisera
raised against a fusion protein of the N-terminal region of KCNQ2
( -KN2), the C-tail of KCNQ3 ( -KC3), or the
N terminus of KCNQ5 ( -KN5). The precipitated proteins
were resolved in 8 or 15% polyacrylamide denaturing gels, and the
channels or CaM were then detected by Western blotting. The association
between CaM and KCNQ subunits was more clearly detected in lysates
processed in the absence of Ca2+. C, control
lysate; pI, preimmune serum. Molecular masses in kDa are
indicated on the left of the figure.
|
|
When specific antisera were used to immunoprecipitate KCNQ3 and KCNQ5
from solubilized membranes of stable HEK293 cell lines expressing these
subunits,2 CaM was present in the immunoprecipitate in
Ca2+-free conditions. As for KCNQ2, in the presence of
Ca2+, less CaM appeared to be associated with these
subunits (Fig. 1). Moreover, no CaM was detected when preimmune
antisera were used. Thus, we concluded that native neuronal KCNQ
channels interact preferentially with apo-CaM.
Mapping of the KCNQ Regions Necessary for the Interaction with
CaM--
Extensive studies have shown that CaM binds to amphipatic
-helices (6-8). To detect potential
-helices within the
C-terminal region of KCNQ channels, we used two secondary structure
prediction algorithms (GOR4 and Predator; www.expasy). These
algorithms highlighted four regions with a high probability of forming
an
-helix in several members of the KCNQ channel family (Fig.
2B, helices A-D). Helix D corresponds to the putative assembly domain (13, but see Ref.
14), and helix C corresponds to the A domain (15). We tested the
capacity of all of these potential
-helical domains to interact with
CaM using the high copy plasmid two-hybrid CLONTECH system (pGBKT7 bait, pGADT7 prey). Although the proximal C-terminal region (that include helices A and B) interacted with CaM, distal regions including helices B, C, and D did not (Fig. 2C).
Similarly, a region including helix A
(Gly310-Ser448) or helix B and part of helix C
(Ser448-Asp549) did not bind CaM. We next
performed a series of lateral and internal deletions in the KCNQ2
C-terminal amino acid sequence. As a result of analyzing these
deletions, we determined that the binding of CaM required the
simultaneous presence of two discontinuous regions (helix A
(Gly310-Tyr372) and helix B
(Thr501-Glu529); Fig. 2C).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 2.
Helices A and B are required for CaM
interactions. A, schematic topological representation
of KCNQ channels. B, probability of -helix content of the
C-terminal region of KCNQ channels using the Predator algorithm
(filled symbols) or GOR4 algorithm (open
symbols). The C-terminal region of the five known members of the
KCNQ family have being aligned using the Clustal method (DNAstar
software). At some positions the program introduced gaps in one or more
sequences. The average score at the positions where none of the five
sequences presented a gap are displayed, highlighting four regions
(helices A-D) with a high -helix content probability.
C, schematic representation of the constructs in the
C-terminal region that were analyzed for their interaction with CaM.
Constructs that did not interact with CaM are represented in
black. The production of the Myc-tagged bait protein was
verified by Western blot using an anti-Myc antibody. The shaded
boxes indicate the two regions required for interaction with
CaM.
|
|
Several consensus sites for CaM binding have already been described (6,
7). A closer analysis of the region that contains helix A showed that
it includes a sequence that resembles the IQ CaM binding motif and that
this is conserved among several members of the KCNQ family (Fig.
3A). Mutations within the IQ motif have been shown to abolish the interaction between CaM and neurogranin in a two-hybrid assay (16) or to alter the
Ca2+-dependent regulation of ion channels (17).
We introduced several point mutations to determine whether amino acids
within the IQ domain are necessary for the interaction of KCNQ2 with
CaM. These mutations included Ile340
Ala,
Ile340
Glu, Ser342
Asp, and
Ala343
Asp.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 3.
Identification of key residues for CaM
binding using the two-hybrid assay. A, alignment of
helix A of KCNQ channels with the IQ-binding motif. B, the
effect of point mutations of key residues on CaM binding. C,
alignment of helix B of KCNQ channels indicating two overlapping
1-5-10 CaM binding motifs. D, the effect of Ser Asp
mutations at the positions indicated of KCNQ2-BD on CaM binding.
E, representative examples of the growth of yeast
co-transformed with the indicated KCNQ C-tail mutants. WT,
wild type scores; +, pale blue signal in the
-galactosidase assay; , no detectable blue signal.
|
|
Amino acid alignment of the IQ motifs indicates that Ala343
of KCNQ2 corresponds to Ser36 of neurogranin (not shown).
Mutating Ser36
Ala of neurogranin makes the IQ motif of
neurogranin resemble that of KCNQ2 and does not affect (or may even
increase) CaM binding. However, mutating Ser36
Asp,
thereby introducing a negative charge that mimics the effect of protein
kinase C, abolishes the interaction between neurogranin and CaM in the
two-hybrid assay (16). Similarly, we found that the interaction between
CaM and the KCNQ2 bait was lost in the equivalent Ala343
Asp mutant. The interaction was also disturbed when the
Ile340
Ala and Ile340
Glu mutations
were introduced, and the Ser342
Asp mutation appeared
to partially perturb CaM binding because the filter
-galactosidase
assay took longer to develop and gave a weaker signal (Fig.
3E). Thus, it appears that the IQ binding motif is necessary
to sustain CaM binding in the yeast two-hybrid assay.
Helix B contains two overlapping 1-5-10 CaM binding motifs (Fig.
3C and Ref. 7). We determined whether the introduction of
negative charges in this region affected CaM binding in a manner similar to that used when they are introduced into key positions of the
IQ binding motif. Within helix B of KCNQ2 there are three protein
kinase C phosphorylation consensus sites (Ser511,
Ser523, and Ser530), and thus we investigated
the effect of introducing a negative charge (mutating Ser
Asp) at
these positions to mimic the effect of phosphorylation. We also
evaluated the effect of mutating serine 406, which is also a potential
target for protein kinase C but that lies in a region not required for
CaM binding. As expected, the introduction of an aspartate at position
406 did not alter CaM binding (not shown). In contrast, the interaction
with CaM was lost when serine 511 was mutated to aspartate
(Ser511
Asp) but appeared to be only slightly affected
(the signal was fainter than for the wild type) when the other serine
residues were mutated (Fig. 3, D and E). These
results suggest that protein kinase C might regulate the binding of CaM
to KCNQ2 channels through the phosphorylation of
Ser511.
To further characterize the interaction between CaM and the KCNQ
channels, we performed GST pull-down experiments (Fig.
4). Different fragments of the C-terminal
region of KCNQ2 were fused in frame to GST, and their binding to
apo-CaM and Ca2+-CaM was compared with that of
GST-neurogranin and GST fused to the C-terminal region of the NR1
subunit (18). The association of purified recombinant rat CaM to fusion
proteins was analyzed both in the absence and in the presence of
Ca2+. Western blots probed with a monoclonal anti-CaM
antibody showed that the fragments including helix A (aa 310-451) or
helix B (aa 445-548) bound CaM in the presence of Ca2+
(Fig. 4). In the absence of Ca2+, helix A did not bind CaM,
whereas helix B appeared to show a weak interaction with CaM. In the
two-hybrid assay, both of these regions appeared to be incapable of
interacting with CaM; however, as discussed later, this can be
explained by the failure to detect interactions with
Ca2+-CaM with the two-hybrid assay.

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 4.
GST pull-down experiments. GST fusion
proteins of the A, B, or AB domains were tested for their ability to
interact with CaM in the absence (5 mM EGTA) or presence (2 mM Ca2+) of Ca2+. GST-neurogranin
(Nrg, aa 1-78) and GST-NR1 (fused to the C0C1C2 C-terminal
region of the NR1 receptor, aa 818-922) were used as positive controls
to demonstrate interactions with apo-CaM and Ca2+-CaM,
respectively. Domains A and B bound CaM much better in the presence
than in the absence of Ca2+, whereas domain AB bound CaM
better in the absence of Ca2+.
|
|
A GST fusion protein containing the most C-terminal region of KCNQ2 (aa
549-844) was incapable of binding CaM in either the presence or the
absence of Ca2+. In contrast, CaM was pulled down
independently of the presence of Ca2+ (although more CaM
was pulled down in absence of Ca2+) when the GST fusion
included a fragment that contained helices A and B (aa 310-548; Fig.
4), again indicating that CaM interacts directly with KCNQ channels.
The interaction of CaM with the C-terminal tail of KCNQ2 was studied by
fluorimetry (Fig. 5). The fluorescence spectrum of CaM dansylated at
Lys75 is shifted, and the intensity increases when the
environment of the fluorophore becomes hydrophobic (19). Dansyl-CaM was incubated with GST, GST-helix A, GST-helix B, or GST-helices A+B fusion
proteins, and the changes in fluorescence emission induced by the
interaction were studied in the presence (2 mM
Ca2+) and absence of Ca2+ (in the presence of 5 mM EGTA). As previously shown, GST alone had no effect on
the emission spectrum of dansyl-CaM independent of the
[Ca2+] (20). In the presence of Ca2+ and
equimolar concentrations of the GST fusion proteins that included
helices A and B or helix B alone, modest changes in the fluorescent
emission were detected. These changes were even more modest in the
presence of the GST-helix A fusion protein. In contrast, a substantial
enhancement in fluorescence was observed in the absence of
Ca2+ with the GST-helices A+B fusion protein. Using a
series of dansyl-CaM concentrations (50-400 nM), the
EC50 estimated in the absence of Ca2+ for
GST-AB binding to dansyl-CaM ranged from 186 to 320 nM.
Under similar conditions, the change in fluorescence remained modest with the GST-helix B fusion and could not be detected with the GST-helix A fusion. In addition, no synergism was seen in the enhancement of fluorescent emission when both GST-helix B and GST-helix
A were used together. Thus, the most significant changes in
fluorescence were seen when both helices are part of the same polypeptide, suggesting that in the absence of Ca2+, this
peptide folds in such a way that it provides a better CaM-binding site
than helix B alone (Fig. 5).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 5.
Changes in dansyl-CaM fluorescence induced by
GST-Helix A, GST-Helix B, and GST-Helices A+B. Emission spectrum
of dansyl-CaM (200 nM) alone and when mixed with GST fusion
proteins in the absence (A) and presence of Ca2+
(B) is shown. The fluorescence spectrum of dansyl-CaM was
determined upon excitation at 340 nm.
|
|
The role of helices A and B was further examined by transiently
expressing in HEK cells mutant KCNQ2 channels in which the helices were
deleted and assessing their ability to associate with CaM by
immunoprecipitation. CaM was not co-immunoprecipitated by antisera
against KCNQ2 in cells expressing mutants devoid of helix A (
IQ
Leu339-Thr358,
pIQ
Trp359-Met371), helix B (
Ser511-Ser523), or both (
IQ+
; Fig.
6). In contrast, the deletion of aa
372-493 did not appreciably inhibit CaM binding (Fig. 6A).
In addition, we analyzed the point mutant Ser342
Asp,
which gave a weak signal in two-hybrid assay (Fig. 3E). With
this mutant, CaM was only seen to co-immunoprecipitate with the channel
in the absence of Ca2+. In contrast, the association of CaM
was not observed with the Ser511
Asp mutant in the
presence or absence of Ca2+. Thus, the results of the
co-immunoprecipitation experiments paralleled those obtained in the
two-hybrid assay, reinforcing the proposal that both helices are
necessary for interaction with CaM in the intact channel.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 6.
Co-immunoprecipitation of KCNQ2 deletion
mutants. A, membrane preparations from HEK293T cells
transiently expressing KCNQ2 mutants were solubilized and
immunoprecipitated with -KN2 antisera in the absence ( ) or
presence (+) of Ca2+ (with the addition of 5 mM
EGTA or 2 mM Ca2+, respectively). The
precipitated proteins were resolved in 8 or 15% polyacrylamide
denaturing gels to detect the channels or CaM by Western blotting,
respectively. The association between CaM and IQ, pIQ, and 
was detected neither in the presence nor the absence of
Ca2+ condition. The deleted amino acids were: IQ
L339-T358, pIQ W359-M371, and  S511-S523. B, CaM
was co-immunoprecipitated with the Ser342 Asp in the
absence of Ca2+, but an interaction was not detected with
the Ser511 Asp mutant in any Ca2+
condition. WT, wild type.
|
|
Determinants in CaM That Are Required for Binding to KCNQ--
CaM
is composed of four Ca2+-binding helix-loop-helix motifs,
called EF hands. These are arranged in two pairs, each pair forming a
distinct domain or lobe. The domains are arranged in a dumbbell-like conformation at the ends of a flexible central helix (aa 65-92). The
N-terminal lobe (aa 1-77) contains EF hands 1 and 2, and the C-terminal lobe (aa 78-148) contains EF hands 3 and 4. It is thought that, in evolutionary terms, CaM arose by duplication of a gene that
represented one lobe. As a consequence EF hands 1 and 3 are alike, and
EF hand 2 is most similar to EF hand 4 (8). Ca2+ binds to
the four EF hand motifs in a highly cooperative manner. First it
associates with EF hands 4 and 3, and subsequently it associates with
EF hands 2 and 1. The binding of Ca2+ to the EF hands
results in the creation of a surface that serves as an interface for
the association of CaM with the target protein. Each lobe can control
distinct processes in the target protein (21, 22), and binding to a
target can change the affinity for Ca2+ (23).
To investigate the role of the different EF hands, we studied the
interaction of a mutated CaM where the first aspartate of EF hands 2, 3, and 4 has been replaced with alanine and another CaM mutated at EF
hands 3 and 4. These Asp to Ala mutations in the EF hands greatly
diminish or abolish their ability to bind Ca2+ (21, 24,
25). Both mutants were able to interact with the C-terminal region of
KCNQ2 or KCNQ3, although less strongly than wild type CaM. In the
liquid galactosidase assay the intensity of the signal obtained with
the EF-2,3,4 mutant was ~40% of wild type CaM (not shown, but see
Fig. 7C).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 7.
CaM domains involved in binding to KCNQ
channels. A, the two-hybrid binding assay detected an
interaction of CaM with targets known to interact with apo-CaM
(C-terminal region of SK2) as well as for the C terminus of KCNQ2,
KCNQ3, and P/Q voltage-dependent calcium channels. No
interaction was seen for targets known to interact with
Ca2+-CaM (C-terminal region of the NMDA receptor (C0C1C2),
the CaM-binding region of myosin light chain kinase), or the C-terminal
region of Eag voltage-dependent potassium channels. The
regions used were: SK2, 390-707; KCNQ2, 510-550; neurogranin
(Nrg), 1-78; P/Q, 1761-2213; NR1, 815-922; Eag,
666-1307; and myosin light chain kinase (MLCK), 959-1332.
B, full-length CaM was required for binding to KCNQ
channels. The fragments of CaM indicated were tested for interaction
with KCNQ2-BD and KCNQ3-BD. The whole C-terminal region of SK2 was used
as a positive control. The CaM fragments tested were: EF12, 1-82;
EF34, 78-148; EF123, 1-132; EF234, 42-148; EF1, 1-46; and EF4,
109-148. C, EF hand 1 (and EF hand 3 to a lesser degree) is
important for the interaction of CaM with KCNQ2-BD in the two-hybrid
assay. The interaction of CaM with an Asp Ala mutation at the
indicated EF hands was tested in the two-hybrid assay. D,
scores of interaction with the different EF hand mutants. +,
growth in His medium but without a clear blue signal in
the -galactosidase assay; +++, strong -galactosidase
signal.
|
|
The determinants for this interaction were further studied using the
low copy number pPC97 (bait) and pPC86 (prey-CaM) vectors. These
plasmids produce more physiological levels of protein than the ones
used to perform the previous experiments. Thus, this low copy number
system allows for better discrimination of small changes in binding
strength caused by the point mutations introduced into either the bait
or the prey. It has been proposed that this two-hybrid assay only
detects Ca2+-independent interactions with CaM (21). While
this still remains unclear (26), this may be an important technical
consideration to bear in mind given the difficulties encountered in
identifying the site of interaction of apo-CaM to some proteins (27).
As mentioned earlier, we found that in vitro, helix A and
helix B can associate with Ca2+-CaM (Fig. 4), although we
were unable to detect this interaction in vivo with the
two-hybrid assay. This is in keeping with Keen's proposal
(21). Moreover, using this assay, we were unable to detect an
interaction of CaM with baits known to interact with Ca2+-CaM but not with apo-CaM (baits such as the C-terminal
region of the NMDA receptor (18); the Eag potassium channel (28); and
the CaM binding site of myosin light chain kinase (7)). Conversely,
when neurogranin, which binds to apo-CaM but not to Ca2+-CaM, was used (7), a clear interaction could be seen
(Fig. 7A).
We tested fragments of CaM to determine which regions were required for
binding to KCNQ2 and to KCNQ3 (Fig. 7B). We also studied the
interaction of CaM with the full C-terminal region of SK2 potassium
channel as well as neurogranin and the C-terminal region of P/Q calcium
channel for reference (16, 21, 29). As previously reported, we found
that the C-terminal lobe of CaM (aa 78-148, EF-3,4) interacted with
the C-terminal domain of SK2 (21). In contrast, full-length CaM
(i.e. the four EF hands) was required to bind to the
C-terminal AB region of KCNQ2 or KCNQ3 subunits.
CaM carrying different combinations of EF hands mutated at the first
aspartate were tested for their ability to associate with the AB region
of KCNQ2 (Fig. 7C). Although apo-CaM binds to both the SK
(25) and KCNQ family of channels, there is no significant sequence
homology in the C-terminal region of these K+ channels. It
has been reported that CaM carrying mutations in any or all
combinations of the EF hands associates with a fragment of the
C-terminal region of SK2 (aa 390-487) (21). In the experiments reported here we used a longer bait (aa 390-707) that produced a
weaker signal (i.e. the strength of the interaction of the
hybrid proteins is closer to the threshold level of detection). With the full C-terminal region of SK2, the assay produced a signal that was
difficult to detect when either EF hands 3 or 4 were mutated alone or
in combination (M3, M4, and M34). Because it has been clearly
demonstrated that EF hands 3 and 4 directly mediate the interaction of
apo-CaM with SK2 channels (21, 23), these results indicate that the
strength of binding is reduced when Asp
Ala mutations are
introduced into these EF hands, sometimes to below the threshold of detection.
In contrast to SK, the interaction with the KCNQ2 or KCNQ3-AB region
was lost or deficient when EF hands 1 or 3 were mutated (M1, M3, and
M13), suggesting that these EF hands directly mediate the interaction
of apo-CaM with KCNQ channels. In addition, the complementary M1 and M3
mutants (M234 and M124) retained the ability to interact with the
KCNQ-AB region. Interestingly, whereas M1 did not bind to the KCNQ-AB
region, the interaction was partially recovered when EF hands 1 and 2 were mutated simultaneously (M12 and M124), suggesting the existence of
important cross-talk between EF hands 1 and 2 that influences the
binding of CaM to KCNQ channels. Similarly, the interaction was
recovered when EF hands 1 and 4 were mutated simultaneously (M14 and
M124), indicating that both CaM lobes are functionally interconnected
when interacting with the KCNQ-AB region.
 |
DISCUSSION |
We have demonstrated here that CaM binds to the intracellular
C-terminal domain of neuronal KCNQ2, KCNQ3, and KCNQ5 transmembrane channels. Two-hybrid experiments suggest that CaM also binds to KCNQ1
and KCNQ4, but more experiments are necessary to unequivocally confirm
this interaction. The voltage-dependent channels to which members of this family of proteins contribute have been implicated in a
variety of physiological processes and pathologies. As a result, the
modulation of the activity of these channels through intracellular
signaling is important in maintaining the physiological homeostasis of
nervous tissue (30). An example of this can be seen in the
Ca2+-dependent regulation of M channels (made
up of KCNQ subunits) that influences the firing rate of the sympathetic
cells in which they are expressed. Our results indicate that through
its association with these proteins, CaM may mediate the
Ca2+-dependent modulation of channels that
include KCNQ subunits.
In addition to demonstrating here that CaM associates with members of
the KCNQ family, we have also defined its binding site. The binding
site identified in this study is unusual in that it is composed of two
discontinuous regions, helix A and helix B. Helix A contains an IQ-like
binding motif, a motif (IQXXXRXXXXR) that
mediates apo-CaM binding in a variety of proteins (31) and that
contains positively charged residues at positions 6 and 11. When
compared with other IQ motifs, in the helix A of the KCNQ channels the
second Arg is replaced by a negatively charged or neutral amino acid.
As a result, this domain resembles the second "incomplete" IQ motif
on myosin II, the region to which the regulatory myosin light chain
(structurally similar to CaM) binds. A model of apo-CaM binding derived
from this and other light chain structures bound to myosin IQ motifs
reveals that the initial portion of this motif (IQXXXR) is
the most critical part. Moreover, it is this region that is
specifically recognized by the loop between EF hands 3 and 4 and that
determines a semi-open lobe conformation (32). In accordance with this
model, the interaction of KCNQ2 with CaM is destabilized when point
mutations are introduced in this first part of the IQ motif.
On many occasions, the C lobe of CaM has been shown to be that which
interacts with peptides, as also occurs with CaM-like proteins that
associate with peptides. Moreover, the bound peptide essentially
occupies the same position relative to the C-terminal EF hand domain
(33). The finding that the C lobe is sufficient to bind to SK channels
(21), P/Q Ca2+ channels, and neurogranin supports this
finding. However, in contrast, it appears that to bind to KCNQ2 or
KCNQ3 channels, both the C and N lobes are required.
Surprisingly, we found that when using the full-length C-terminal
region of SK2 as bait, point mutations that abolish Ca2+
binding to EF hands 3 or 4 also abrogate the interaction with CaM.
There is, however, ample biochemical, functional, and structural evidence to indicate that Ca2+ is not bound to EF hands 3 or 4 when CaM interacts with SK2. In addition, it has been shown that
the Ca2+-free C-terminal lobe is that which mediates the
binding of CaM to the SK2 CaM-binding domain (21, 23). Our results
indicate that mutating the first aspartate to alanine in the EF hands
that directly mediate the interaction of apo-CaM with the target causes a reduction in the binding strength. By analogy with the SK2
CaM-binding domain, the observation that the interaction of CaM with
KCNQ2 or KCNQ3 does not tolerate point mutations at EF hand 1 and (to a
lesser degree) 3 suggests that binding to the KCNQ-BD is mainly mediated by the apo-EF hands 1 and 3. Interestingly, EF hand 1 is most
similar to EF hand 3 (8), suggesting that both play a similar role in
stabilizing the target complex.
The difficulties in identifying apo-CaM interactions have been
highlighted by Erickson et al. (27). To overcome this
problem, a very elegant technique has been developed, three-cube
fluorescence resonance energy transfer, that demonstrates the
preassociation of CaM with calcium channels in living cells (27). The
yeast two-hybrid system is another viable alternative for approaching this problem. Our results provide further evidence that the two-hybrid assay is capable of detecting interactions between the
Ca2+-free form of CaM and target proteins such as the SK2
K+ channels (21). It should be born in mind that a
limitation of the two-hybrid system is that the transmembrane segments
of target proteins must be eliminated to allow targeting of the bait to
the nucleus (34). However, the main advantage is that this is a
relatively simple assay and that it does offer us the opportunity to
study protein-protein interactions in a living cell (16).
The recent resolution of the structure of CaM associated with the
SK-binding domain has shown that the binding domain is composed of two
-helices connected by a short loop (23). The high probability that
the two KCNQ regions contain
-helices suggests that a similar conformation to the SK2 CaM-binding domain may also arise in KCNQ. However, some differences are evident. Although in SK channels the
connecting loop is only 5 aa long, in KCNQ channels this varies from
~100 to ~150 aa. Secondly, the C lobe of CaM (EF hands 3 and 4) is
sufficient for binding to SK channels (21), whereas the complete CaM
molecule is necessary for binding to KCNQ2 or KCNQ3 channels. In
essence, our data suggests that the C-terminal domain of KCNQ channels
folds in such a way that helix A and helix B form a compact structure
that can be engulfed between the N- and C-terminal lobes of apo-CaM
(Fig. 8).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 8.
Model of the interaction of CaM with KCNQ
channels. The main features of the model are that helix A and
helix B come into close proximity in the tertiary structure and are
engulfed by CaM. The S6 transmembrane segment and pore region of only
two subunits of a tetrameric potassium channel are shown for clarity.
The relative orientation of helix A of the two subunits is a suggestion
based on the proposed structure of cyclic nucleotide gated channels
(36). The crystal structure of KcsA potassium channel (S6 and pore)
(39) and the crystal structure of the SK potassium channel binding
domain complexed with CaM (23) have been used as templates to draw this
cartoon to scale.
|
|
What is the role of CaM in KCNQ function? The preassociation of apo-CaM
to a target protein whose activity may be regulated by CaM generally
ensures a rapid and selective response to local elevations in
Ca2+ (8, 27). Indeed, the suppression of the M current by
bradykinin in rat sympathetic neurons is mediated by this cation (3), and apo-CaM has been shown to modulate the
Ca2+-dependent gating of many channels (27,
35). The Ca2+-dependent modulation of M
channels can also be observed in excised patches. Under these
conditions, signaling pathways such as phosphorylation are not
supported, and because the effects observed are fully reversible, it
becomes very unlikely that the modulation of IM via Ca2+ is due to dephosphorylation of the M channel or of
an associated protein. Furthermore, the absence of a "signature"
flickering behavior and the tendency to "desensitize" in inside-out
patches (i.e. the effect is transient) suggests that the
activity of Ca2+ does not involve the direct blockage of
the internal mouth of the channel (4). These observations indicate that
the mediator exists in limited amounts in excised patches and that it
is washed out after the application of Ca2+. These
properties suggest the involvement of a Ca2+ sensor such as
CaM, which, as we have shown, interacts with the C-terminal
intracellular region of KCNQ channels. In this respect, it is
interesting to reflect on the fact that helix A is adjacent to the end
of S6, the last transmembrane domain (Fig. 8). In other channels with a
similar six transmembrane architecture, such as SK
Ca2+-activated K+ channels and cyclic
nucleotide-gated channels, gating is modulated by a module that
attaches to the end of S6 (23, 36). However, we should also bear in
mind that the binding of CaM may also be important in other processes
such as assembly or trafficking (37, 38). The functional analysis of
mutants unable to bind CaM should help to unveil the role of CaM in
KCNQ channel function.
 |
ACKNOWLEDGEMENTS |
We are very grateful to Drs. J. Maylie
(Oregon Health Sciences University), T. Jentsch (Zentrum
für Molekulare Neurobiologie Hamburg, Hamburg, Germany), L. M. Pardo and W. Stühmer (Max Planck Institute, Göttingen,
Germany), A. Villalobo and J. Bernal (Instituto de
Investigaciones Biologicas-Consejo Superior de Investigaciones Cientificas, Madrid, Spain), W. A. Catterall (University of
Washington), B. J. Jensen (NeuroSearch, Ballerup, Denmark),
V. I. Teichberg (Weizmann Institute of Science, Rehovot,
Israel), J. T. Stull (University of Texas Southwestern Medical Center,
Dallas, TX), and S. Pons (I Cajal, Madrid, Spain) for providing us
with cDNAs and other materials used in this study. We thank Dr.
Paula Bosch and Dr. Fernando Diaz for providing equipment and help in
the fluorimetric assays. We acknowledge the help of Dr. Fernando Moro and Dr. M. Paz Regalado in some parts of the project, Dr. Mark Sefton
for critical comments on the manuscript and editorial help, and Carmen
Page and Uyen Le for technical assistance.
 |
FOOTNOTES |
*
This work was supported by European Union Grant
QLGT-1999-00827, Fondo de Investigaciones Sanitarias Grant FIS01/1136),
Comunidad de Madrid Grant 08.5/0011/2001.1, and Spanish Ministry of
Education Grant SAF2000-0159).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
34-91-585-4718; Fax: 34-91-585-4754; E-mail: av@cajal.csic.es.
Published, JBC Papers in Press, May 24, 2002, DOI 10.1074/jbc.M204130200
2
E. Yus-Nájera, A. Muñoz, J. DeFelipe, and A. Villaroel, manuscript in preparation.
 |
ABBREVIATIONS |
The abbreviations used are:
CaM, calmodulin;
apo-CaM, apo-calmodulin, Ca2+-free calmodulin;
Ca2+-CaM, Ca2+-bound calmodulin;
IQ, calmodulin
binding motif;
GST, glutathione S-transferase;
dansyl, 5-dimethylaminonaphthalene-1-sulfonyl;
aa, amino acid(s).
 |
REFERENCES |
| 1.
|
Jentsch, T. J.
(2000)
Nat. Rev. Neurosci.
1,
21-30[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Wang, H. S.,
Pan, Z.,
Shi, W.,
Brown, B. S.,
Wymore, R. S.,
Cohen, I. S.,
Dixon, J. E.,
and McKinnon, D.
(1998)
Science
282,
1890-1893[Abstract/Free Full Text]
|
| 3.
|
Cruzblanca, H.,
Koh, D. S.,
and Hille, B.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
7151-7156[Abstract/Free Full Text]
|
| 4.
|
Selyanko, A. A.,
and Brown, D. A.
(1996)
Neuron
16,
151-162[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Saimi, Y.,
and Kung, C.
(2002)
Annu. Rev. Physiol.
64,
289-311[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
O'Neil, K. T.,
and DeGrado, W. F.
(1990)
Trends Biochem. Sci.
15,
59-64[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Rhoads, A. R.,
and Friedberg, F.
(1997)
FASEB J.
11,
331-340[Abstract]
|
| 8.
|
Jurado, L. A.,
Chockalingam, P. S.,
and Jarrett, H. W.
(1999)
Physiol. Rev.
79,
661-682[Abstract/Free Full Text]
|
| 9.
|
Biervert, C.,
Schroeder, B. C.,
Kubisch, C.,
Berkovic, S. F.,
Propping, P.,
Jentsch, T. J.,
and Steinlein, O. K.
(1998)
Science
279,
403-406[Abstract/Free Full Text]
|
| 10.
|
Villarroel, A.,
and Regalado, M. P.
(1997)
Trends Genet.
13,
164[CrossRef]
|
| 11.
|
Hayashi, N.,
Matsubara, M.,
Takasaki, A.,
Titani, K.,
and Taniguchi, H.
(1998)
Protein Expression Purif.
12,
25-28[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Romey, G.,
Attali, B.,
Chouabe, C.,
Abitbol, I.,
Guillemare, E.,
Barhanin, J.,
and Lazdunski, M.
(1997)
J. Biol. Chem.
272,
16713-16716[Abstract/Free Full Text]
|
| 13.
|
Schmitt, N.,
Schwarz, M.,
Peretz, A.,
Abitbol, I.,
Attali, B.,
and Pongs, O.
(2000)
EMBO J.
19,
332-340[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Smith, J. S.,
Iannotti, C. A.,
Dargis, P.,
Christian, E. P.,
and Aiyar, J.
(2001)
J. Neurosci.
21,
1096-1103[Abstract/Free Full Text]
|
| 15.
|
Schwake, M.,
Pusch, M.,
Kharkovets, T.,
and Jentsch, T. J.
(2000)
J. Biol. Chem.
275,
13343-13348[Abstract/Free Full Text]
|
| 16.
|
Prichard, L.,
Deloulme, J. C.,
and Storm, D. R.
(1999)
J. Biol. Chem.
274,
7689-7694[Abstract/Free Full Text]
|
| 17.
|
Zühlke, R. D.,
Pitt, G. S.,
Deisseroth, K.,
Tsien, R. W.,
and Reuter, H.
(1999)
Nature
399,
159-162[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Ehlers, M. D.,
Zhang, S.,
Bernhadt, J. P.,
and Huganir, R. L.
(1996)
Cell
84,
745-755[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Mori, M.,
Konno, T.,
Ozawa, T.,
Murata, M.,
Imoto, K.,
and Nagayama, K.
(2000)
Biochemistry
39,
1316-1323[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
El Far, O.,
Bofill-Cardona, E.,
Airas, J. M.,
O'Connor, V.,
Boehm, S.,
Freissmuth, M.,
Nanoff, C.,
and Betz, H.
(2001)
J. Biol. Chem.
276,
30662-30669[Abstract/Free Full Text]
|
| 21.
|
Keen, J. E.,
Khawaled, R.,
Farrens, D. L.,
Neelands, T.,
Rivard, A.,
Bond, C. T.,
Janowsky, A.,
Fakler, B.,
Adelman, J. P.,
and Maylie, J.
(1999)
J. Neurosci.
19,
8830-8838[Abstract/Free Full Text]
|
| 22.
|
DeMaria, C. D.,
Soong, T. W.,
Alseikhan, B. A.,
Alvania, R. S.,
and Yue, D. T.
(2001)
Nature
411,
484-489[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Schumacher, M. A.,
Rivard, A. F.,
Bachinger, H. P.,
and Adelman, J. P.
(2001)
Nature
410,
1120-1124[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Geiser, J. R.,
van Tuinen, D.,
Brockerhoff, S. E.,
Neff, M. M.,
and Davis, T. N.
(1991)
Cell
65,
949-959[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Xia, X. M.,
Fakler, B.,
Rivard, A.,
Wayman, G.,
Johnson-Pais, T.,
Keen, J. E.,
Ishii, T.,
Hirschberg, B.,
Bond, C. T.,
Lutsenko, S.,
Maylie, J.,
and Adelman, J. P.
(1998)
Nature
395,
503-507[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Hisatsune, C.,
Umemori, H.,
Inoue, T.,
Michikawa, T.,
Kohda, K.,
Mikoshiba, K.,
and Yamamoto, T.
(1997)
J. Biol. Chem.
272,
20805-20810[Abstract/Free Full Text]
|
| 27.
|
Erickson, M. G.,
Alseikhan, B. A.,
Peterson, B. Z.,
and Yue, D. T.
(2001)
Neuron
31,
973-985[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Schonherr, R.,
Lober, K.,
and Heinemann, S. H.
(2000)
EMBO J.
19,
3263-3271[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Lee, A.,
Wong, S. T.,
Gallagher, D., Li, B.,
Storm, D. R.,
Scheuer, T.,
and Catterall, W. A.
(1999)
Nature
399,
155-159[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Marrion, N. V.
(1997)
Annu. Rev. Physiol.
59,
483-504[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Bahler, M.,
and Rhoads, A.
(2002)
FEBS Lett.
513,
107-113[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Houdusse, A.,
Silver, M.,
and Cohen, C.
(1996)
Structure
4,
1475-1490[Medline]
[Order article via Infotrieve]
|
| 33.
|
Atkinson, R. A.,
Joseph, C.,
Kelly, G.,
Muskett, F. W.,
Frenkiel, T. A.,
Nietlispach, D.,
and Pastore, A.
(2001)
Nat. Struct. Biol.
8,
853-857[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Niethammer, M.,
and Sheng, M.
(1998)
Methods Enzymol.
293,
104-122[Medline]
[Order article via Infotrieve]
|
| 35.
|
Levitan, I. B.
(1999)
Neuron
22,
645-648[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Johnson, J. P. J.,
and Zagotta, W. N.
(2001)
Nature
412,
917-921[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Gao, T.,
Bunemann, M.,
Gerhardstein, B. L., Ma, H.,
and Hosey, M. M.
(2000)
J. Biol. Chem.
275,
25436-25444[Abstract/Free Full Text]
|
| 38.
|
Joiner, W. J.,
Khanna, R.,
Schlichter, L. C.,
and Kaczmarek, L. K.
(2001)
J. Biol. Chem.
31,
699-711
|
| 39.
|
Doyle, D. A.,
Morais, C. J.,
Pfuetzner, R. A.,
Kuo, A.,
Gulbis, J. M.,
Cohen, S. L.,
Chait, B. T.,
and MacKinnon, R.
(1998)
Science
280,
69-77[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.